Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454322 · ClinicalTrials.gov registry record
The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 300
- Enrollment target
NCT02454322: Completed study, sponsored by Northwestern University.
NCT02454322 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454322 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
Magnesium is sometimes used to prevent seizures in the setting of hypertensive disorders of pregnancy. The primary aim of this study is to determine if women who receive magnesium are less likely to experience postpartum depression. Other aims include examining the relationship between receiving magnesium and cognitive function and birth experience.
Primary Outcome
The frequency of postpartum depression at 2 weeks and 6 weeks postpartum
Interventions
- DRUG Magnesium Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2015-05 |
| Est. Completion | 2021-12 |
What the finished NCT02454322 record still lists
NCT02454322 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Magnesium Sulfate is the first listed.
NCT02454322 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02454322 about?
NCT02454322 is a clinical study titled "The Effect of Magnesium on Maternal Mood, Cognitive Function, and Birth Experience". Magnesium is sometimes used to prevent seizures in the setting of hypertensive disorders of pregnancy. The primary aim of this study is to determine if women who receive magnesium are less likely to experience postpartum depression. Other aims include examining the relationship between receiving mag...
What is the current status of trial NCT02454322?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2015-05. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02454322?
The interventions under investigation include: Magnesium Sulfate (DRUG).
Who is sponsoring clinical trial NCT02454322?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia